" The Eyes Have it " : Ocular Saccade Abnormalities in Prodromal Alzheimer's Disease

Alzheimer's Disease Clinical Trial

— LYLO  

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01630525
• Other study ID #: CHUBX 2011/22
• Status: Completed
• Phase: N/A
• First received: June 21, 2012
• Last updated: January 22, 2016
• Start date: December 2012
• Est. completion date: December 2015

Study information

• Verified date: January 2016
• Source: University Hospital, Bordeaux
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
• Study type: Observational

Clinical Trial Summary

Alzheimer's disease (AD) has a prolonged prodromal phase before the stage of dementia. Subtle executive cognitive function deficits can be detected at this early pre-dementia phase, more than 10 years before dementia. Among them, the digit symbol substitution task (DSST) has been shown to be altered very early, up to 13 years before dementia. This test, as many others executive function tests, requires a fine control of visuomotor coordination. Like executive functions, eye movements, particularly voluntary-guided saccades, are under the control of the frontal lobe and fronto-parietal networks. Previous studies have shown a deterioration of voluntary saccades in AD using various paradigms. There are no data in prodromal AD, although the pathological process of the disease affects very early brain structures implicated in saccades execution (eg. caudate nucleus and pre-cuneus).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 83
• Est. completion date: December 2015
• Est. primary completion date: December 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

All patient groups:

• Age >60 years

• Normal vision work-up : (corrected binocular visual acuity > 8/10)

• Written informed consent

• Subjects affiliated to Social Security

Group A: Prodromal AD.

• Memory complaints.

• Normal or slight restriction of IADL.

• "hippocampal-type" amnesic syndrome defined by poor free recall despite adequate (and controlled) encoding, decreased total recall because of insufficient effect of cuing or impaired recognition, numerous intrusions (RL/RI-16items)

• CDR (Clinical Dementia Rating Scale) = 0,5

• Persistence of memory changes at a subsequent assessment (>3 months)

• Absence of global cognitive deterioration (MMSE =24)

• Exclusion of other disorders that may cause mild cognitive impairment with adequate tests

• 1.5 Tesla diagnosis MRI with at least T2, Flair transversal sections and coronal T1 sections in the coronal plan. Absent or slight medio temporal/hippocampal atrophy or if available (non mandatory) characteristic CSF betaA42/tau ratio

Group B: Typical AD (mild to moderate)

• NINDS-ADRDA diagnosis criteria

• MMSE = 20

Group C: Control subjects

• No memory or other significant cognitive complain.

• MMSE = 24

Exclusion Criteria:

All groups :

• Clinically significant vision abnormality(P8 without glasses)

• Oculomotor deficit or strabismus

• Depression (GDS) with treatment

• Subjects unable to give their informed consent

Controls :

• Memory or any other significant cognitive complain.

• Abnormalities at inclusion (V0) neuropsychology testing suggestive of a cognitive deficit.

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Alzheimer Disease
• Alzheimer's Disease

Intervention

Other:
• Neuropsychological assessment
Neuropsychological assessment : MMSE (Greco), RL/RI-16 items (Van der Linden 2003), visual retention test (DMS48), verbal fluency (Thurstone et Thurstone 1964), TMT A and B (Reitan 1956), DSST (Weschler 1997), Clinical Dementia Rating Scale (Hughes 1982), image naming DO80 (Deloche et Hannequin 1997), Similarities and Digit Span subscores of the WAIS (Weschler 1997), Anxiety and Depression (GDS), activities of daily living (ADL-Katz and IADL-Lawton).
• ophthalmologic checkup
Vision work-up, 30 minutes (VA, non invasive retinal imaging : non dilated optic fundus picture or OCT, ocular tension).
• Automated non-invasive oculometry
Automated non-invasive oculometry : 45 minutes with rest periods : horizontal and vertical pro- and anti-saccades, prediction, spatial decision (Monsiman et al. Brain 2005,128:1267-127, items detection (Rösler et al. Cortex 2005 ;41 :512-519) and exploration/curiosity of non congruent images and faces according to Daffner et al. Neurology 1992 ;42 :320-328 and Loughland et al. Biol Psychiatry 2002 ;52 : 338-348).

Locations

Country	Name	City	State
France	Lyon UniversityHospital	Lyon
France	AP-HM	Marseille
France	CHU de Bordeaux Hôpital Haut Lévêque	Pessac

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Bordeaux

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Saccades execution parameters	To demonstrate the alteration of saccade execution parameters (latency, velocity, precision, errors) during pro and anti-saccades, spatial decision and prediction tasks in prodromal AD compared to mild to moderate AD and aged-matched controls.; Variables recorded : Saccades execution parameters : Mean latency (msec),; Mean velocity (°/msec) and maximal velocity,; Accuracy or mean gain,; Mean percent of errors and corrected errors,; Mean percent of prediction.	Study visit (Up to 1 month after inclusion)	No
Secondary	Neuropsychology tests scores		At inclusion (Day 0)	No
Secondary	Pre-defined variables on visual exploration tasks (fixation number and durations, errors).		Study visit (Up to 1 month after inclusion)	No
Secondary	Number of point fixation in degraded areas and of visual attention induced cards		Study visit (Up to 1 month after inclusion)	No